Digital Health & AI
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
![](https://cdn.statically.io/img/hbw.citeline.com/-/media/editorial/hbw-insight/2024/07/hbw2407_team_s_1414443335.jpg?rev=f2d7c882120e434ea84060ed306a678c&w=350&hash=75111A55086FCB2B6BD176367C2FBEC6)
US Wellness Market People News: Martha Stewart Supplements, Cheribundi Olympians, More
Martha Stewart sells supplements on iHerb; Cheribundi partners spread the brand at Paris Games; GoodSport’s latest partner is a Bear; Herbalife-sponsored runner competes in ultramarathons; Dutch researcher joins Unicity science board; and Beacon Wellness adds sales strategy chief.
![](https://cdn.statically.io/img/hbw.citeline.com/-/media/editorial/hbw-insight/hbw-stock-images/hbw0724_personalized_supplements_2279017321_1200.jpg?rev=fc9dc2c5314e494ebb351bb56321302e&w=350&hash=4BD89EB1B9A28A65533AA701C417A7A3)
AI-Driven Wellness Firm Bioniq Raises $15m For Supplement Market Disruption
Bioniq's latest “oversubscribed” funding round will finance the global expansion of its AI-powered personalized supplement offer, the firm says.
![](https://cdn.statically.io/img/hbw.citeline.com/-/media/editorial/hbw-insight/2024/07/hbw2407_q2crosswinds.jpg?rev=5f97ab6d113a4991ae3921fdb9d0998b&w=350&hash=11CEB3ECAC18BC758237AB8ED3ABE8FC)
US Consumer Health Q2 Earnings Preview: If Not For Headwinds, Tailwinds Would Be Trending
Analysts tracking consumer health product firms in the US anticipatevApril-June results lower than a year ago across most businesses. While some results will be lower on comparisons with strong growth in 2023, others will reflect a slow allergy season, retailers’ inventories remaining high as consumer spending slows or firms continuing to recover from supply chain problems.
![](https://cdn.statically.io/img/hbw.citeline.com/-/media/editorial/hbw-insight/2024/07/hbw2407_petroslist_s_2239866755-(1).jpg?rev=52f9411f8a5b4fa0b893935394e9bc88&w=350&hash=B1DB320A8FFF56EE358D8C994DC19E2B)
Petros’ ED Drug OTC Self-Selection Study Checks Nitrate Patient, ACNU Switch ‘Fail First’ Boxes
Study with 509 subjects conducted in Petros’ preparation of OTC switch application demonstrated 90.6% correct self-selection for participants using its web app technology and DFL and 57.3% correct by subjects using only DFL.
![](https://cdn.statically.io/img/hbw.citeline.com/-/media/editorial/pink-sheet/2024/06/ps2406_coming-soon_1856521276-1200.jpg?rev=36defe04c5af427e85c9cb23b33ae019&w=350&hash=728B97BD400D201C4FCC27CA1D3FDBB8)
US FDA Guidance On Artificial Intelligence For Regulatory Decision-Making Expected This Year
Draft guidance will offer a risk-based framework for accessing the credibility of AI and help ensure that AI models used to answer regulatory questions are sufficiently credible for a particular ‘context of use,’ CDER’s Tala Fakhouri says.
![](https://cdn.statically.io/img/hbw.citeline.com/-/media/editorial/hbw-insight/00_regular-column-images/hbw_over_the_counter_1200.jpg?rev=d61008da33564bb98e25a66fcefbdc81&w=350&hash=C6FB897CA2354C67C52F20248F28706E)
Over The Counter: How To Innovate For The Ages, With Bayer’s Reese Fitzpatrick And Rachel Koontz
Aspirin is celebrating its 125th anniversary this year. To find out what brand owner Bayer Consumer Health is doing to celebrate this occasion, and what it is doing to take the brand into the next 125 years, HBW Insight chats with the company’s senior vice president, Global Head Allergy, Cough/Cold, Pain and Heart Health, Reese Fitzpatrick, and head of R&D, North America and Therapeutics, Rachel Koontz.
![](https://cdn.statically.io/img/hbw.citeline.com/-/media/editorial/hbw-insight/2024/06/hbw2406_amazon-shopping_1992003269.jpg?rev=5dbea48ec951476f829a0579975b5576&w=350&hash=C9C06559A687845B758F5C4BACFD2151)
Estee Lauder Companies Has Opened Three Branded Storefronts On Amazon Since March
Bumble and bumble follows Too Faced and Clinique, also with their own storefronts within Amazon’s Premium Beauty space. Lauder notes the broader reach and the importance of meeting consumers where they already are shopping.
![](https://cdn.statically.io/img/hbw.citeline.com/-/media/editorial/hbw-insight/2024/06/hbw2406_chessboardx_s_339519653.jpg?rev=bb01c4f2670e403fb848c21d3b14f790&w=350&hash=77D9C0620A4DA5F60D9B15C58244A507)
US Wellness Market Movers: Doctor’s Best, Society Brands, CharmHealth
Doctor's Best acquires Viactiv calcium and magnesium brand from Guardion; VitaliyNow is Society Brands’ third 2024 acquisition; and VitaminLab formulation services on CharmHealth.
![](https://cdn.statically.io/img/hbw.citeline.com/-/media/editorial/medtech-insight/2024/06/mti2406_hltheurope_verily_lightpath_1200.png?rev=f4f9659726234d52bc3435a58ed475d0&w=350&hash=3A966E5CAAAF8AF38B6F3B2DFC0F84F8)
‘Is This Doomsday Concern, Or Is It Reality?’ Verily CMO On AI’s Future, Lightpath Metabolic, More
Andrew Trister, Verily’s chief medical and scientific officer, discusses Verily’s newly launched Lightpath Metabolic solution, featuring GLP-1 prescription, AI and strengthened clinical support. Plus, the Google health tech spinout's plans for the Study Watch, the Alzheimer’s research landscape, and AI development and regulation in a new era of uncertainty.
![](https://cdn.statically.io/img/hbw.citeline.com/-/media/editorial/hbw-insight/hbw-stock-images/hbw0624_onlineadvertising_1936412359_1200.png?rev=4a2e5ae7e2f840b29a630544247b4d09&w=350&hash=B2F27EF7437E32B05292F6DBED25B2B1)
AESGP Publishes Guidance For EU Companies Advertising Self-Care Products Online
When it comes to online consumer health product advertising, complying with regulations, ensuring that content is factually correct and being transparent are some of the key principles that companies should adhere to, recommends AESGP in a recently published position paper.
![](https://cdn.statically.io/img/hbw.citeline.com/-/media/editorial/scrip/2022/02/sc2201_chess_race_et0w8g_1200.jpg?rev=7e82c411dfd344189767ebf5426ed25a&w=350&hash=70431B7E5EE75A38276E8031CEC64227)
AI Act: How To Preserve EU’s Industrial Competitiveness Through Proportionate Regulation
The AI medtech revolution could be a “huge, missed opportunity” for the EU without an effective and efficient regulatory infrastructure. Answers are needed fast, MedTech Europe’s Oliver Bisazza said during a recent interview.
![](https://cdn.statically.io/img/hbw.citeline.com/-/media/editorial/medtech-insight/2024/06/mti2406_medtechbrain_holographic_medicine_2200141975_1200.png?rev=a58ad3964694418c9e0b95dc396e918c&w=350&hash=C9AC6D69E2F6BBB612B80912066B5518)
Click Therapeutics Anticipates Pharma Will Begin Developing Digital Drugs From Clinical Stage
Leading digital therapeutic maker’s CEO David Benshoof Klein and CMO Shaheen Lakhan discuss outlook on the DTx space, priorities going forward, and what makes Click a standout player in a changing game.
![](https://cdn.statically.io/img/hbw.citeline.com/-/media/editorial/hbw-insight/2024/hbw0624_sanofi_1200.jpg?rev=1ab47618e4fb4c6aa9b9d69558cbef76&w=350&hash=3D507A95DC464E54C00FDACEC66B7F91)
AESGP Meeting: Real World Evidence Could Drive Rx-To-OTC Switch, If Regulators Embrace It
Real-world data and evidence, for example generated by digital consumer health technology like apps and wearables, could provide crucial support for Rx-to-OTC switch applications, argues Sanofi Consumer Healthcare’s Penny Glover at the Association of the European Self-Care Industry's 60th Annual Meeting in Brussels, Belgium. Recent research by Sanofi indicates that regulators are actually already using RWD and RWE in many cases when assessing switch applications, even if they do not call it that.
![](https://cdn.statically.io/img/hbw.citeline.com/-/media/editorial/hbw-insight/2024/06/hbw_2406_ai_kid.jpg?rev=dc96050bf86244a080317903c0be0f32&w=350&hash=7342064D24E0B36BB7267A10F9BB3B2D)
CARU Puts Brands On Notice: Guidelines For Children’s Advertising Extend To AI
The BBB National Programs, Inc.’s Children’s Advertising Review Unit reminds advertisers its Advertising and Privacy Guidelines extend to the use of AI in ads for children and points them to its recent warning that it will ‘strictly enforce’ those guidelines.
![](https://cdn.statically.io/img/hbw.citeline.com/-/media/editorial/hbw-insight/2024/hbw0624_shukla_1200.jpg?rev=ff307d1a17094be98ebb85a84393cac2&w=350&hash=6D9372C1BB10BF25C89010327C501546)
AESGP Annual Meeting: OTC Firms Must ‘Innovate Harder’ To Realize Growth Opportunity
Industry can look forward to a global OTC market compound annual growth rate of around 7% over the next few years, according to IQVIA Consumer Health. Innovation will be key to ensure individual companies realize this level of growth. IQVIA CH's Amit Shukla and Simon-Kucher & Partners' Clemens Oberhammer point to some key consumer trends to keep an eye on at the recent AESGP Annual Meeting in Brussels.
![](https://cdn.statically.io/img/hbw.citeline.com/-/media/editorial/hbw-insight/2024/06/hbw0624_bcg_1200.jpg?rev=8cf4a07374fc45eeb3bf425b7fc2b106&w=350&hash=6453A2B9D54D18C8DA5BC1FA7A5889F3)
AESGP Meeting: Climate Inaction Could Cost Healthcare Companies 10-20% Operating Profit
Failing to take sufficient action on climate change could be a costly business for consumer health companies. However, the good news from the AESGP's 60th Annual Meeting in Brussels, Belgium, is that at least half of the cost of decarbonizing will be balanced by savings, according to Boston Consulting Group. And climate change adaption will present firms with a wide variety of opportunities for product innovation, IQVIA Consumer Health's Volker Spitzer tells delegates.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.